Standardization of a Heat Tolerance Test for Young Women as a Basis for Heat Tolerance Tests in Female Soldiers

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Medical Corps, Israel Defense Force.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Medical Corps, Israel Defense Force
ClinicalTrials.gov Identifier:
NCT01221038
First received: October 13, 2010
Last updated: July 12, 2011
Last verified: June 2011
  Purpose

Background:

Heat stroke is defined as a condition where the body temperature raises to dangerous level that may cause harm to body tissues and lead to multi-system clinical and pathological manifestations that might lead to death. Among heat stroke survivors a defect in thermoregulation develops as a consequence. In the IDF, every soldier who had a heat stroke, or is suspected to have had a heat stroke, must pass a heat intolerance test in the Unit of Military Physiology, after a rest period of 4-6 from the incident, which is the approximate period for thermoregulation to recuperate from the injury after a heat stroke. Until the heat intolerance test, the soldier must not train to avoid a repeat incident of heat stroke. The soldiers' ability to return to active duty is based on the results of the exam. The heat tolerance test and its criteria have been developed in the Physiology Unit throughout years of experience, and have been proved and adopted by several labs in Europe and in the United States. The criteria generally include baseline temperature and heart rate, and are based upon the physiological response of healthy men (soldiers) in the physical effort involved in the test.In recent years there is a growing trend in the IDF to integrate female soldiers in combat divisions. As a result, these females are exposed to physical efforts in various climate conditions as a part of their training, or a part of their active duty missions in the division. Therefore, the probability of an incidence of heat injuries increases among these soldiers.Research results indicate differences in the efficiency of thermoregulation mechanisms between men and women:

It has been found that in women the threshold for sweating and vasodilatation is higher than in males. Additionally, although in women the mechanism for sweating is slower, and occurs at a later period, it is found that the relative part of sweating that evaporates is higher, so that women evaporate sweat more efficiently (to make up for the lower sweat quantities compared to men). Reduced efficiency of the thermoregulation mechanisms in women is also attributed to the differences in mass, body composition (fat and muscle mass), and physical fitness between the genders. In addition, the physiological changes that occur during the different phases of the menstrual cycle can affect core temperature at rest and thermoregulation. Different reports in literature indicate a decreased thermoregulation capacity in the luteal phase of the menstrual cycle compared to the follicular phase. Apparently, thermoregulation capabilities in exercise are linked to progesterone blood levels, which are influenced by contraceptive pills and with the phase of the menstrual cycle.

There are two factors that can cause incorrect diagnosis of the level of heat tolerance in females when the specific test is interpreted based on set criteria for men. These criteria are:

  1. The physiological differences between men and women
  2. The differences in women based on menstrual cycle and using contraceptive pills.

Thus, there is a need to characterize and establish the normal values in a heat tolerance test for young females compared to males, and also to correspond to current menstrual cycle phase and use of contraceptive pills.

Methods:

on the first day of the research, the participants will undergo anthropometric examinations (measuring height, weight, BMI, fat content, maximum oxygen consumption). In addition, the participants will undergo a heat tolerance test protocol. The heat tolerance test will be conducted twice in every participant - once in the follicular phase of the menstrual cycle, and a second time in the luteal phase of the cycle. During the protocol, the following information will be collected from each participant: heart rate, core temperature, skin temperature in three locations (chest, arm, and leg), oxygen consumption and liquid balance.

The results of the examination will be compared to results of male participants who have previously undergone the heat tolerance test in the Unit of Military Physiology.

Contribution to IDF:

the research will allow administrating heat tolerance tests accurately and reliably to female soldiers that have been affected by heat injuries or are suspected to be heat intolerant.


Condition
Heat Tolerance

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Preliminary Study for Standardization of Heat Tolerance Test for Young Women

Resource links provided by NLM:


Further study details as provided by Medical Corps, Israel Defense Force:

Primary Outcome Measures:
  • The physiological load in women [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    The physiological load will be mesured during a heat tolerance test (HTT) and will be compared to the physiological load during an HTT in men.


Secondary Outcome Measures:
  • Rectal temperature [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    The rectal temperature will be mesured by a rectal thermistore.

  • Skin temperature [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    The skin temperature will be mesured during an HTT by skin thermistores conected to 3 sites (chest, leg and arm).

  • Heart rate [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    The heart rate will be mesured by a polar watch.

  • Sweat rate [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    The sweat rate will be calculeted from the subject's weight before and after the HTT and from his water balance.


Estimated Enrollment: 30
Study Start Date: February 2011
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
group 1
young women not using OC
group 2
young women using OC
group 3
young men (database)

  Eligibility

Ages Eligible for Study:   20 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

young health women

Criteria

Inclusion Criteria:age 20-30 year, no past medical history, BMI 20-29, physically active, after completion of medical questionnaire and physical examination -

Exclusion Criteria:heart diseases, respiratory diseases,resting BP>140/90, DM, anhydrosis, skin diseases, pregnancy, breast feeding, using OC continuously, acute illness in the past two weeks.

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01221038

Contacts
Contact: Amit Druyan, M.D Amit.Druyan@sheba.health.gov.il

Locations
Israel
Sheba medical center Recruiting
Ramat Gan, Israel
Sponsors and Collaborators
Medical Corps, Israel Defense Force
Investigators
Principal Investigator: Amit Druyan, MD International Diabetes Federation
  More Information

No publications provided

Responsible Party: Amit Druyan, Heler Institute
ClinicalTrials.gov Identifier: NCT01221038     History of Changes
Other Study ID Numbers: 923-2010-CTIL
Study First Received: October 13, 2010
Last Updated: July 12, 2011
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

ClinicalTrials.gov processed this record on July 22, 2014